Director

The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth.
The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC). Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).
The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Trueta, Hospital del Mar, and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.
We are seeking a DIRECTOR for our institute Main responsibilities Nurture a stimulating environment for interdisciplinary and translational research in leukaemia and other hematologic malignancies.Define the overall scientific, technological, and innovation vision for the institute.Foster an institutional culture encompassing collaboration, communication, integrity, transparency, collegiality, and scientific creativity with the ultimate goal of finding a cure for leukaemia and other hematologic malignancies.Essential Duties and Responsibilities Define and manage the IJC Strategic Plan and the research activities program of the institute, submit them to the members of the Board of Trustees, and coordinate their execution.Guarantee financial sustainability and provide for sources of income (competitive funds, private sponsors, etc.).Co-supervise the economic activities of the institute with the Administrative Director and supervise the scientific human resources management, with direct involvement in those issues related to selection or adscription of research positions.Develop the scientific career in the institute, assuring transparency and equal opportunities.Represent the Institute at official and social events, in coordination with the President and other members of the Board of Trustees.Perform any other functions that might be approved by the Board of Trustees.Strategic development and leadership Foster a stimulating environment for top research in leukaemia and other hematologic malignancies and define the overall scientific and technological vision for the institute.Provide leadership and support for the research groups of the IJC and ensure the best conditions and excellence for IJC activities.Lead strategic actions aimed at securing the resources necessary for the institute's objectives.Direct, organize, manage, and execute the research, training, and internal organization of the institute.Propose programs of activities, new research lines, and, when appropriate, potential sources of funding to the Board of Trustees.Keep CERCA and the Generalitat de Catalunya regularly informed of the Institute's progress.Foster value creation through knowledge and technology transfer and other innovation activities.Establish and run an internationally competitive research laboratory pursuing research lines aligned with the institute's mission.Explore and foster new partnerships on the national and international level that will increase the impact of IJC's science.Be an effective spokesperson and communicator to all key stakeholders including funders, politicians, journalists, and others.Establish effective communication with the managers, clinical departments, and scientific advisors of the six IJC-associated hospitals and with their respective research institutes.Endorse and transmit the core values of the IJC (Scientific and Social Ethic, Interdisciplinarity, Equality and diversity, Creativity, Perseverance, continuous improvement, and sustainability).Provide guidance to all members of the institute, especially to the strategic, technology transfer, academic, and technical departments of the institute.Support effective training, career development, and mentoring at all levels, consistent with the aims of the IJC's Equality and Diversity programme.Create an executive and effective management structure by appointing an Administrative Director and, if appropriate, intermediate research managers and scientific advisors.Jointly approve the internal rules of operation of the institute with the Administrative Director and in agreement with the Board of Trustees.Assure quality monitoring on all levels by overseeing scientific evaluations and participate in the periodic CERCA evaluation of the IJC.Engage with the community of research centres within the CERCA System and SOMM alliance.Director's Profile PhD or comparable degree in Life Sciences and Health.Distinguished record of scientific excellence in Biomedicine. Since the IJC has been awarded the Severo Ochoa Accreditation for institutional excellence in 2024, the candidate will need to meet the criteria of scientific excellence defined by the MCIU.Previous experience in leukaemia or other hematologic malignancies.Leadership experience, maintaining the highest ethical standards, honesty, transparency, and trustworthiness, and valuing diversity, equality, and inclusion.Communication skills necessary for managing a multicampus research institute.Knowledge of strategic planning, resource allocation, and human resources management.Experience in managing international research projects. Knowledge of international research programs (H2020, NIH, etc.) will be considered as a value.Good knowledge of the requirements for clinical research and capacity to connect basic, translational, and clinical research.Knowledge of the Spanish and Catalan Scientific, Health, and University system.Professional experience in an inter-institutional environment will be considered as a value.Ambition to further develop IJC to a world-wide reference centre for research on hematologic malignancies.Positive evaluation in programs of professional excellence in the field of research (ERC, ICREA, etc.) will be considered an added value.Interest to develop research activities as senior group leader that are aligned with the institute's mission.Track record of responsibility in research and innovation. Experience in value generation and tech transfer is an added value.Proficiency level in English. The candidate should learn Catalan or Spanish in a period of 12 months after starting in the Director's position.Experience in management of research between centres or institutions at different locations will be considered an added value.The possibility of immediate incorporation into the IJC will be positively valued.What we offer Initial appointment for 5 years and extension pending confirmation of the Board of trustees.Salary, start-up package, and space commensurating track record and expertise.The opportunity to contribute to the consolidation and further development of a unique, disease-focused institute.Access to the research infrastructure of IJC and its partners including state-of-the-art core facilities in banking of samples, Microarrays/Optical Genome Unit, bioinformatics, flow cytometry, genomics, proteomics, microscopy, and single cell omics.The stimulating environment of the multi-locations institute, Biomedical Campus Can Ruti, and the Barcelona metropolitan area.Selection process Until 01/12/2024 the call will be opened. Applicants should send their CV, up to 2 recommendation letters + 1 application letter to the Director of CERCA at ****** by December 1st, 2024.
15/12/2024: Report of preselected candidates by SAB
December 2024- January 2025: Preselected candidates will be asked to prepare a vision statement for the institute and will be interviewed by the selection committee, composed of members of the board of trustees.

#J-18808-Ljbffr